Table 3.
Unadjusted and adjusted associations between liver fibrosis indices and outcomes.
| Multivariable adjustment OR (95%CI) | ||||
|---|---|---|---|---|
| Outcome | Event, n (%) | FIB−4 cutoff 3.25 | APRI cutoff 0.7 | Forns cutoff 6.9 |
| Mortality at 90 days | 411/3722(11%) | 1.35(1.02–1.77) | 1.39(1.08–1.78) | 1.53(1.11–2.12) |
| Mortality at 180 days | 466/3722(12.5) | 1.37(1.05–1.78) | 1.44(1.13–1.82) | 1.57(1.15–2.13) |
| Mortality at one year | 527/3722(14.2) | 1.38(1.07–1.77) | 1.42(1.13–1.78) | 1.58(1.18–2.13) |
| Mortality at three years | 527/3722(14.2) | 1.40(1.09–1.79) | 1.34(1.07–1.69) | 1.65(1.23–2.21) |
| Acute kidney injury | 176/3722(4.7%) | 1.43(0.99–2.08) | 1.16(0.82–1.66) | 1.27(0.82–1.97) |
| Pneumonia | 976/3722(26.2) | 1.05(0.85–1.29) | 1.02(0.85–1.23) | 1.27(1.00–1.63) |
| Hydrocephalus | 391/3722(10.5) | 1.00(0.75–1.32) | 0.99(0.76–1.29) | 1.34(0.96–1.86) |
| Rebleeding | 183/3722(4.9%) | 1.64(1.14–2.36) | 1.69(1.22–2.34) | 1.54(1.01–2.36) |
| Delayed cerebral ischemia | 698/3722(18.8) | 1.00(0.81–1.24) | 1.19(0.98–1.44) | 1.14(0.88–1.49) |
APRI, Aspartate Aminotransferase/Platelet Ratio Index; FIB−4, Fibrosis−4.